Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Pharming Group Logo
Pharming Group Growth Score
76
CB Rank
158216
Heat Score
27
Pharming Group is a biopharma company that develops protein replacement therapies and precision medicines.
Founded
obfuscation
PrivateDebt Financing Leiden, Zuid-Holland, The Netherlands251-500 www.pharming.com
Biopharma
Health Care
Manufacturing
Pharmaceutical
Precision Medicine
Overview

Pharming Group
Total Funding
obfuscation
Growth Score
76
Heat Score
27

Total Funding
obfuscation
obfuscation
Debt Financing raised
obfuscation
Growth Score76
-11 pts
in past quarter
Heat Score 27
-7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Pharming Group

CB Rank
158216
Pharming Group is a biopharma company that develops protein replacement therapies and precision medicines.
Founded
obfuscation
PrivateDebt Financing Leiden, Zuid-Holland, The Netherlands251-500 www.pharming.com
Biopharma
Health Care
Manufacturing
Pharmaceutical
Precision Medicine

Funding Rounds

Debt Financing
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

  • Photo of Leverne Marsh
    Leverne Marsh: Chief Commercial Officer
    Past Role: Dexcom, Executive Vice President of Global Marketing
  • Photo of Kenneth Lynard
    Kenneth Lynard: Chief Financial Officer
    Past Role: Schoeller Allibert, Managing Director & Group CFO

Details

Legal Name Pharming Group N.V.
Operating Status Active
Company Type For Profit
Phone Number 31 71 5247 400
Contact Email info@pharming.com
Predictions & Insights

Growth Insight

See this Growth Insight
Pharming Group is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

Leniolisib
An oral precision medicine for treating activated phosphoinositide 3-kinase delta syndrome (APDS) and other primary immunodeficiencies with immune dysregulation.
Protein Replacement Therapies
Therapies that replace deficient or defective proteins in patients with rare diseases to restore normal biological function.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Debt Financing - Pharming Group Logo
Debt Financing - Pharming Group
2
obfuscation
Oxford Finance LLC, Silicon Valley BankDebt Financing
obfuscation
Debt Financing - Pharming Group Logo
Debt Financing - Pharming Group
2
obfuscation
Oxford Finance LLC, Silicon Valley BankDebt Financing
obfuscation
Debt Financing - Pharming Group Logo
Debt Financing - Pharming Group
2
obfuscation
Oxford Finance LLC, Silicon Valley BankDebt Financing
obfuscation
Debt Financing - Pharming Group Logo
Debt Financing - Pharming Group
2
obfuscation
Oxford Finance LLC, Silicon Valley BankDebt Financing
obfuscation
Debt Financing - Pharming Group Logo
Debt Financing - Pharming Group
2
obfuscation
Oxford Finance LLC, Silicon Valley BankDebt Financing

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Debt Financing - Pharming Group Logo
Debt Financing - Pharming Group
2
obfuscation
Oxford Finance LLC, Silicon Valley BankDebt Financing
obfuscation
Debt Financing - Pharming Group Logo
Debt Financing - Pharming Group
2
obfuscation
Oxford Finance LLC, Silicon Valley BankDebt Financing
obfuscation
Debt Financing - Pharming Group Logo
Debt Financing - Pharming Group
2
obfuscation
Oxford Finance LLC, Silicon Valley BankDebt Financing
obfuscation
Debt Financing - Pharming Group Logo
Debt Financing - Pharming Group
2
obfuscation
Oxford Finance LLC, Silicon Valley BankDebt Financing
obfuscation
Debt Financing - Pharming Group Logo
Debt Financing - Pharming Group
2
obfuscation
Oxford Finance LLC, Silicon Valley BankDebt Financing

Investors

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 251-500 Employee Profiles 3 Board Members and Advisors 2 Contacts 188

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

12,326
-56.99%
 in past month

IT Spend

$8.3MThis year, Pharming Group is projected to spend $8.3M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Smartsheet Logo
Smartsheet
98
Smartsheet Inc. Logo
Smartsheet Inc.
98
Best Places to Live Logo
Best Places to Live
94

Actively Used Products

28Pharming Group uses 28 technology products and services including HTML5, Lightbox, and  Google Tag Manager, according to G2 Stack.

Total IP

2The intellectual property of Pharming Group includes 2 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Pharming Group's headquarters? Pharming Group is located in Leiden, Zuid-Holland, The Netherlands.Who invested in Pharming Group? Pharming Group has 3 investors including Silicon Valley Bank and  Oxford Finance LLC.When was the last funding round for Pharming Group? Pharming Group closed its last funding round on
obfuscation
from a Debt Financing round.Who are Pharming Group's competitors? Alternatives and possible competitors to Pharming Group may include Sanofi, Takeda, and  Amgen.How much funding has Pharming Group raised to date? Pharming Group has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3a5fd92 1)
|